Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)

NCT06658522 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension PAH
Pulmonary Arterial Hypertension WHO Group I
Pulmonary Arterial Hypertension

Interventions

DRUG: Sotatercept

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]